Replication of somatic micronuclei in bovine enucleated oocytes
© Canel et al.; licensee BioMed Central Ltd. 2012
Received: 6 August 2012
Accepted: 15 November 2012
Published: 22 November 2012
Microcell-mediated chromosome transfer (MMCT) was developed to introduce a low number of chromosomes into a host cell. We have designed a novel technique combining part of MMCT with somatic cell nuclear transfer, which consists of injecting a somatic micronucleus into an enucleated oocyte, and inducing its cellular machinery to replicate such micronucleus. It would allow the isolation and manipulation of a single or a low number of somatic chromosomes.
Micronuclei from adult bovine fibroblasts were produced by incubation in 0.05 μg/ml demecolcine for 46 h followed by 2 mg/ml mitomycin for 2 h. Cells were finally treated with 10 μg/ml cytochalasin B for 1 h. In vitro matured bovine oocytes were mechanically enucleated and intracytoplasmatically injected with one somatic micronucleus, which had been previously exposed [Micronucleus- injected (+)] or not [Micronucleus- injected (−)] to a transgene (50 ng/μl pCX-EGFP) during 5 min. Enucleated oocytes [Enucleated (+)] and parthenogenetic [Parthenogenetic (+)] controls were injected into the cytoplasm with less than 10 pl of PVP containing 50 ng/μl pCX-EGFP. A non-injected parthenogenetic control [Parthenogenetic (−)] was also included. Two hours after injection, oocytes and reconstituted embryos were activated by incubation in 5 μM ionomycin for 4 min + 1.9 mM 6-DMAP for 3 h. Cleavage stage and egfp expression were evaluated. DNA replication was confirmed by DAPI staining. On day 2, Micronucleus- injected (−), Parthenogenetic (−) and in vitro fertilized (IVF) embryos were karyotyped. Differences among treatments were determined by Fisher′s exact test (p≤0.05).
All the experimental groups underwent the first cell divisions. Interestingly, a low number of Micronucleus-injected embryos showed egfp expression. DAPI staining confirmed replication of micronuclei in most of the evaluated embryos. Karyotype analysis revealed that all Micronucleus-injected embryos had fewer than 15 chromosomes per blastomere (from 1 to 13), while none of the IVF and Parthenogenetic controls showed less than 30 chromosomes per spread.
We have developed a new method to replicate somatic micronuclei, by using the replication machinery of the oocyte. This could be a useful tool for making chromosome transfer, which could be previously targeted for transgenesis.
KeywordsMicronuclei Oocyte Chromosomes Transgene
Manipulation of genetic information has been under investigation for many years. However, manipulation of chromosomes has only been attempted by the generation and use of artificial chromosomes capable of carrying large DNA sequences, e.g. YAC’s (yeast artificial chromosomes) [1, 2] and HAC’s (human artificial chromosomes [3, 4]. Although such molecules can carry large fragments of DNA, the isolation and manipulation of individual entire chromosomes has never been achieved.
In 1974, Ege and Ringertz developed a methodology for generating cells with small amounts of DNA . These cells, having only one or a few chromosomes (microcells) were first fused with mitotic cells to generate hybrid karyotypes by Schor et al. . In 1977, Fournier and Ruddle  designed the microcell-mediated chromosome transfer technique (MMCT) which is still used to introduce a low number of chromosomes into host somatic cells [8, 9]. This technique has been used in several ways, mainly for the mapping of genes, like tumor suppressor genes [10–15], telomerase suppressor genes [16–19], senescence inducing genes [20–22], and genes involved in DNA repair pathways [23–25]. It has also been used to study the effect of genomic imbalances on chromosome- specific gene expression patterns and the behavior of polysomies in different cell lines [26, 27], and for analysis of genomic imprinting [28–30].
Recipient cell types used for MMCT can be somatic cells, embryonic carcinoma (EC) or embryonic stem (ES) cells, which are employed to study in vitro or in vivo effects of the transferred chromosomes . This method consists of the chemical micronucleation of a donor cell line whose chromosome under study contains a dominant selectable marker. Treated cells develop several micronuclei, which contain one or, at most, a few chromosomes. Microcells are then isolated by high speed centrifugation in the presence of cytochalasin B. After a filtration process, microcells with the smallest number of chromosomes are collected and finally fused with recipient somatic cells. The dominant selectable marker previously introduced into donor cells allows recognition of resulting hybrid cell lines which have incorporated the chromosome of interest [32, 33]. In this way, MMCT can be considered as a simple way to manipulate an entire chromosome as a structural unit. Nevertheless, it is not possible to select and replicate such chromosomes individually.
It is well known that the oocyte has the capacity to replicate varied numbers of chromosomes. It has been demonstrated that haploid, polyploid and mixoploid embryos can cleave and also reach the blastocyst stage in the bovine [34, 35], porcine  and human [37–40]. Polyploid blastocysts have also been produced in rabbits  and mice . Additionally, it has been established that the mammalian oocyte can replicate not only the genetic information from the gametes [43, 44], but also from somatic cells [45, 46], including cells from different species . Mouse first polar bodies have also been used as nuclear donors . After injection of polar bodies, enucleated oocytes were subjected to ICSI and fertile offspring were obtained following embryo transfer to foster mothers . In addition, bovine embryos reconstituted with non enucleated oocytes showed similar cleavage and blastocyst rates to those reconstituted with enucleated oocytes . On the basis of these previous results, we can propose that the oocyte is capable of replicating a wide range of numbers and types of chromosomes.
The MMCT technique is still widely used, even though the methodology has not undergone any major technical changes since it was developed. In the present work, we gave a new focus to this technique by using the bovine ooplast to copy a single or low number of chromosomes. With the aim of generating several copies of individual chromosomes to be able to manipulate them, we combined part of the MMCT technique with somatic cell nuclear transfer (SCNT). The new methodology that we designed consists of injecting one somatic micronucleus into an enucleated oocyte and inducing the injected oocyte to cleave. Each blastomere from the injected oocytes should have a copy of the donor micronucleus, giving rise to the replication of an individual chromosome or of a low number of chromosomes.
We also tested the ability of somatic micronuclei to express a transgene after being injected into an ooplast. Recently, we demonstrated a spontaneous and quick interaction between DNA and donor cells or fragments of ooplasm surrounded by oolema (vesicles) . In this study, cumulus cells previously exposed to pCX-EGFP plasmid for 5 min were injected into enucleated bovine oocytes and gave rise to egfp expressing embryos by SCNT. Vesicles exposed to pCX-EGFP were injected into MII oocytes and IVF embryos, resulting in the production of parthenogenetic and IVF egfp expressing embryos respectively. On the basis of these results, we hypothesize that the membranes surrounding micronuclei are also capable of binding DNA, resulting in the production of egfp expressing embryos.
In summary, after chemical activation, cleavage occurred, and some micronuclei were replicated. A low number of chromosomes (1–13) was detected. Additionally, a small proportion of micronuclei- injected oocytes showed transgene expression. The possibility of generating embryos containing only one chromosome would allow us to genetically modify, identify and transfer individual chromosomes, while multiplying them into many blastomeres. In this way, it would be possible to confirm which chromosome has been replicated by the oocyte through biopsy and molecular analysis of only one of the blastomeres. This method constitutes a first approach to individual chromosome manipulation.
Results and discussion
Induction of somatic micronuclei
Evaluation of different combinations of spindle inhibitors and mitomycin for the induction of somatic micronuclei
% Micronucleate cells / total cells
Media of micronuclei / cell
DMC 0.05 μg/ml
DMC 0.1 μg/ml
Col 0.05 μg/ml
Cleavage and egfp expression of enucleated and micronucleus injected bovine oocytes
Cleavage and egfp expression rates of Micronucleus- injected bovine oocytes
egfp expressing embryos (%)
In experiment 2, egfp expression was also analyzed. Interestingly, a low number of Micronucleus- injected (+) embryos showed egfp expression. Expression levels were significantly lower than those observed for the Parthenogenetic (+) control (2.15 vs. 38.74% respectively) and they did not differ from the Enucleated (+) control, which did not show egfp expression at all (p≤0.05). From these data, we can conclude that it is not necessary for the oocyte to have an entire nucleus to allow the transgene to be expressed. According to our hypothesis, the membranes surrounding micronuclei could have bound DNA, or the transgene could also have been transferred in the media during the injection of the micronuclei, as this is the way in which we produced the egfp expressing parthenogenetic control embryos. The transgene was delivered directly into the cytoplasm of the parthenotes by microinjection, before chemical activation. In a previous work done in our laboratory, eDNA alone was injected into MII oocytes in the same way and concentration of pCX-EGFP than in the present study, giving rise to a 25% of egfp expressing embryos at day 4 of in vitro development . In a second study from our group, Bevacqua et al.  reported 50% of egfp expressing embryos, working under the same conditions.
Although egfp expression was observed in Micronucleus- injected group, rates of expression were low. This result could indicate that a non complete nucleus is not as efficient as an entire nucleus to support transgene expression. One possible explanation for the latter observation could be the unusual structure that the micronucleus adopts at the interphase stage. There are several indirect evidences that suggest that the inner nuclear membrane might have a repressor action over transcription of many genes. One of these is that heterochromatin is usually positioned near the periphery of the nucleus . In our work, we used micronuclei as nuclear donors which must have a different content of chromosomes; their transcription (and also those of the transgene) could have been repressed or not, depending on the position of the chromosomes within the nuclear envelope. On the other hand, egfp expression observed in the Enucleated (+) group was zero, while a 38.74% rate of expression shown by the Parthenogenetic (+) control group is evidence that the presence of a nucleus is necessary for transgene expression. These results agree with Spann TP et al.  who reported an association between the normal structure of Xenopus embryo nucleus and the occurrence of transcription.
Chromosomal analysis of micronucleus injected embryos
Ploidy of micronucleus injected bovine embryos
Less than 15 chromosomes (%)
In this study we have demonstrated that bovine ooplasts are capable of replicating micronuclei with a low number of chromosomes. The number of replicated chromosomes in each micronucleus was confirmed to be between 1 and 13. Moreover, it was observed that some of the transferred micronuclei expressed a foreign DNA, which means that it is not necessary for the oocyte to have an entire nucleus to allow the expression of a transgene. For the first time, MMCT was used to produce SCNT embryos, using micronuclei as nuclear donors. In conclusion, we have developed a new method to clone a small number of chromosomes, which could be a useful tool to transfer individual chromosomes and to target transgenesis to a specific area of the genome. In the field of domestic animals production, it could be a strategy for sex chromosomes interchange. It would make it possible to exchange an X chromosome for a Y chromosome, which could have been previously modified to carry a transgene of interest. In this way, the resulting male would be able to produce millions of gametes instead of hundreds and would have the transgene integrated into the Y chromosome, which has a few genes and therefore reduced position effects.
Unless otherwise indicated, all chemicals were purchased from Sigma Chemical Company (St. Louis, MO, USA).
Cumulus–oocyte complexes (COCs) collection and in vitro maturation (IVM)
Cow ovaries were transported from a local slaughterhouse to the laboratory in a thermo container at 24 to 27°C. Cumulus oocyte complexes (COCs) were aspirated from follicles with a diameter of 2–8 mm into Dulbecco’s phosphate-buffered saline (DPBS; 14287–072; Gibco BRL, Grand Island, NY, USA) containing 10% v/v fetal bovine serum (FBS; 10499–044; Gibco BRL) and 1% v/v antibiotic–antimycotic (ATB; 15240–096; Gibco BRL). Oocytes covered with at least three layers of granulosa cells were selected for IVM. The maturation medium was bicarbonate-buffered TCM-199 (31100–035; Gibco BRL), containing 2 mM glutamine (G-8540), 10% v/v FBS, 2 mg/ml follicle-stimulating hormone (NIH-FSH-P1; Folltropin; Bioniche, Belleville, Ontario, Canada), 0.3 mM sodium pyruvate (P2256), 100 mM cysteamine (M9768), and 1% v/v ATB. Groups of 25 COCs were in vitro matured in 100 μL droplets of maturation medium covered with mineral oil (M8410), at 39°C in a humidified atmosphere of 6% CO2 in air. After 21–24 h of IVM, cumulus cells were removed from COCs by vortexing for 3 min in 1 mg/ml hyaluronidase solution (H-4272) and washed three times in HEPES-TALP. Oocytes with an extruded first polar body (PB) were selected for enucleation and intracytoplasmic micronucleus injection or chemical activation.
Preparation of donor cells
Somatic cell cultures were established from slaughtered cow ovaries. Ovarian explants were cultured in 35x100 mm culture dishes (353001; Falcon, USA) with Dulbecco modified Eagle medium (DMEM; 11885 Low glucose; Invitrogen, Grand Island, NY, USA) supplemented with 10% v/v FBS and 3% v/v ATB, at 39°C in a humidified atmosphere of 6% CO2 in air. After about 2 weeks, fibroblast monolayers reached confluence and were removed and placed into new culture dishes. For passages, cells were washed with DPBS and digested with 0.05% trypsin-EDTA (25300; Gibco, Grand Island, NY) for 5 min at 37°C. The reaction was terminated by adding supplemented DMEM and the collected cells were resuspended and divided into new dishes.
Induction of somatic micronucleate cells
Ovarian bovine fibroblasts at approximately 80% confluence with less than 5 passages were blocked in metaphase by incubation with 0.05 or 0.1 μg/ml demecolcine (DMC; D1925); or 0.05 μg/ml colchicine (Col; C3915) in DMEM for 46 or 48 h. In order to complete mitotic arrest, some cells were then incubated with 2 mg/ml mitomycin (Mit; M-4287) for 2 h. The cells were subsequently washed with DPBS and, in all cases, were incubated in DMEM medium supplemented with 10 to 15 μg/ml cytochalasin B (CB; C6762) for 1 h. The six treatments assayed were: DMC 0.05 μg/ml; DMC 0.05 μg/ml + Mit; DMC 0.1 μg/ml; DMC 0.1 μg/ml + Mit; Col 0.05 μg/ml; and Col 0.05 μg/ml + Mit. All treated cells were trypsinized and immediately centrifuged at 1200 r.p.m for 5 min, at 37°C. The pellet was resuspended in 200 μl of FBS-free DMEM medium and the resulting suspension containing micronucleate cells was transferred to 100 μl droplets of TALP-Hepes with 1 mg/ml of Hoechst Bisbenzimide 33342 (H33342, B-2261). After 10 min, cells were observed under a fluorescence microscope to analyze the percentage of micronucleate cells and the number of micronuclei per cell. For injection procedures, cells were exposed to DMC 0.05 μg/ml + Mit + CB 10 μg/ml treatment, then trypsinized and immediately used as nuclear donors as described below.
The plasmid used was pCX-EGFP kindly provided by Dr. Masaru Okabe (Osaka University, Osaka, Japan) that contains the enhanced green fluorescent protein gene (egfp) under the chimeric cytomegalovirus-IE-chicken β-actin enhancer-promoter control . The plasmid was linearized by Hind III digestion.
Enucleation and intracytoplasmic micronucleus injection
After 21 h of IVM, MII oocytes were denuded and stained with 1 mg/ml of H 33342 for 10 min. Immediately, oocytes were transferred into 100 μl droplets of Hepes-TALP supplemented with 0.3 g/ml BSA, under mineral oil, in 100x20 mm tissue culture dishes (430167; Corning, NY, USA) and mechanically enucleated using a Narishige hydraulic micromanipulator (Narishige Sci., Tokyo, Japan) mounted on a Nikon Eclipse E-300 microscope (Nikon, Melville, NY, USA). Enucleation was performed using a 20 μm internal diameter pipette. Metaphase chromosomes were visualized under ultraviolet light (<10 sec) and aspirated into the pipette with a minimal volume of ooplasm. Chromosome removal was confirmed by the presence of stained MII chromosomes inside the pipette. Donor somatic cells were transferred to TALP-Hepes droplets supplemented with 10 μg/ml CB and 1 mg/ml of H 33342. After 10 min, micronucleate cells were identified and transferred to 3 μl droplets of 10% v/v polyvinylpyrrolidone solution (PVP; 99219; Irvine Sci., Irvine, CA, USA) in HEPES-TALP, with or without 50 ng/μl pCX-EGFP for injection. After an incubation of at least 5 min, the cell membrane was broken by gentle aspiration in and out of the injection pipette (inner diameter of 7 μm) and a single micronucleus was injected into the cytoplasm of each enucleated oocyte (Micronucleus- injected groups). Aspiration was used to break the oolemma. The somatic micronucleus and the aspirated ooplasm were then expelled into the oocyte with a minimal volume of PVP (<10 pl). Enucleated and some parthenogenetic controls were injected with 50 ng/μl pCX-EGFP in 10% v/v PVP into the ooplasm, using a volume that was equivalent to that used for to the injection of micronuclei (<10 pl). A parthenogenetic control (non injected) was also included. After injection, all groups were subjected to chemical activation as described below.
Metaphase II oocytes and Micronucleus- injected embryos were treated with 5 μM ionomycin (I24222; Invitrogen, Carlsbad, CA, USA) in HEPES-TALP for 4 min, followed by incubation for 3 h in 1.9 mM 6-DMAP, (D2629) diluted in TCM-199 medium. Afterwards, oocytes were thoroughly washed in HEPES-TALP and cultured as described below. Prior to activation, Micronucleus- injected embryos were held for 2 h in 100 μl droplets of TCM-199 to allow the reprogramming events.
The IVF procedure was previously described by Brackett and Oliphant . Briefly, frozen semen was thawed in a 37°C water bath for 30 sec. The sperm were washed twice by centrifugation at 490g x 5 min with Brackett’s defined medium. Sperm concentration was adjusted to 20x106/ml and sperm were then coincubated for 5 h with COCs in Brackett’s fertilization medium. Afterward, presumptive zygotes were washed several times in HEPES-TALP and in vitro cultured as described below.
In vitro culture
Embryos were in vitro cultured in 50 μl droplets of synthetic oviductal fluid (SOF)  modified by Holm et al.  containing 2.5% v/v FBS under mineral oil, at 39°C in a humidified atmosphere of 6% CO2 in air. Cleavage stage was evaluated at day 2 of in vitro development.
Evaluation of pCX-EGFP expression in embryos
Embryos injected with pCX-EGFP were briefly exposed to blue light using an excitation- filter at 488 nm and an emission-filter at 530 nm to determine egfp expression at day 4 of in vitro development.
Assessment of nuclear replication
Forty-eight hours after activation, Micronucleus- injected and Parthenogenetic embryos were transferred to Hepes-TALP droplets and treated with 1.5 mg/ml pronase for 3 min to remove all zonae pellucidae. Afterward, embryos were fixed with methanol: acetic acid solution (3:1, v: v) and DNA was stained with DAPI (D9542). Nuclei were visualized and counted using UV light under a fluorescence microscope. Embryos with more than one nucleus were considered to have replicated their DNA.
Forty-eight hours after activation, Micronucleus- injected, Parthenogenetic, and IVF embryos were cultured for 6 h in SOF medium containing 1.25 μg/ml colchicine (C3915) and transferred to a trisodium citrate hypotonic solution (F71497; 0.9 % w/v in distilled water) for 13 min at 37°C. Subsequently, embryos were placed on a clean glass slide in a small volume of medium and a methanol: acetic acid solution (3:1, v: v) was applied. After air drying, fixed embryos were stained with 5% v/v Giemsa solution (1.09204.1002; Merck, Darmstadt, Germany) in distilled water for 10 min. Chromosome spreads were examined under a 100X oil magnification objective and chromosomal complements were determined for each embryo which was classified as: less than 15 chromosomes, euploid (1n and 2n), and others, which included tetraploid (4n), mixoploid (embryos with blastomeres of different ploidies), and aneuploid. Only those spreads which were clearly in metaphase were analyzed.
Each experiment was repeated at least three times. Differences between treatments in each experiment were determined by Fisher’s exact test using Graph Pad PRISM® software 5.01 version. Differences between media of micronuclei per cell were analyzed for significance using the one way ANOVA. For all analyses a difference of p≤0.05 was considered to be significant.
The authors are grateful to Dr. Masaru Okabe for kindly providing the construct pCX-EGFP and C.I.A.L.E. for providing bull semen. The authors would also like to thank Dr. Elizabeth Crichton (email@example.com) for her assistance to improve the English and Dr. Rafael Fernández y Martín, Lic. Pablo Zipowicz and Dr. Martín Radrizani for their technical support. The research was supported by funds from the Agencia Nacional de Promoción Científica y Tecnológica (PICT Bicentenario N10–2716).
- Murray AW, Szostak JW: Construction of artificial chromosomes in yeast. Nature 1983, 305: 189–193. 10.1038/305189a0View ArticlePubMed
- Burke DT, Carle GF, Olson MV: Cloning of large segments of exogenous DNA into yeast by means of artificial chromosome vectors. Science 1987, 236: 806–812. 10.1126/science.3033825View ArticlePubMed
- Harrington JJ, Van BG, Mays RW, Gustashaw K, Willard HF: Formation of de novo centromeres and construction of first-generation human artificial microchromosomes. Nature Genet 1997, 15: 345–355. 10.1038/ng0497-345View ArticlePubMed
- Kuroiwa Y, Tomizuka K, Shinohara T, Kazuki Y, Yoshida H, Ohguma A, Yamamoto T, Tanaka S, Oshimura M, Ishida I: Manipulation of human minichromosomes to carry greater than megabase-sized chromosome inserts. Nat Biotechnol 2000, 18: 1086–1090. 10.1038/80287View ArticlePubMed
- Ege T, Ringertz NR: Preparation of microcells by enucleation of micronucleate cells. Exp Cell Res 1974, 87: 378–382. 10.1016/0014-4827(74)90494-7View ArticlePubMed
- Schor SL, Johnson RT, Mullinger AM: Perturbation of mammalian cell division. II. Studies on the isolation and characterization of human mini segregant cells. J Cell Sci 1975, 19: 281–303.PubMed
- Fournier RE, Ruddle FH: Microcell-mediated transfer of murine chromosomes into mouse, Chinese hamster, and human somatic cells. Proc Natl Acad Sci USA 1977, 74: 319–23. 10.1073/pnas.74.1.319View ArticlePubMed CentralPubMed
- Suzuki N, Itou T, Hasegawa Y, Okazaki T, Ikeno M: Cell to cell transfer of the chromatin-packaged human beta-globin gene cluster. Nucleic Acids Res 2010, 38: e33. 10.1093/nar/gkp1168View ArticlePubMed CentralPubMed
- Kazuki Y, Hiratsuka M, Takiguchi M, Osaki M, Kajitani N, Hoshiya H, Hiramatsu K, Yoshino T, Kazuki K, Ishihara C, Takehara S, Higaki K, Nakagawa M, Takahashi K, Yamanaka S, Oshimura M: Complete genetic correction of ips cells from Duchenne muscular dystrophy. Mol Ther 2010, 18: 386–93. 10.1038/mt.2009.274View ArticlePubMed CentralPubMed
- Saxon PJ, Srivatsan ES, Stanbridge EJ: Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells. EMBO J 1986, 5: 3461–6.PubMed CentralPubMed
- Casey G, Plummer S, Hoeltge G, Scanlon D, Fasching C, Stanbridge EJ: Functional evidence for a breast cancer growth suppressor gene on chromosome 17. Hum Mol Genet 1993, 2: 1921–7. 10.1093/hmg/2.11.1921View ArticlePubMed
- Flanagan JM, Healey S, Young J, Whitehall V, Trott DA, Newbold RF, Chenevix-Trench G: Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8. Genes Chromosomes Cancer 2004, 40: 247–60. 10.1002/gcc.20039View ArticlePubMed
- Cheung AK, Lung HL, Ko JM, Cheng Y, Stanbridge EJ, Zabarovsky ER, Nicholls JM, Chua D, Tsao SW, Guan XY, Lung ML: Chromosome 14 transfer and functional studies identify a candidate tumor suppressor gene, mirror image polydactyly 1, in nasopharyngeal carcinoma. Proc Natl Acad Sci USA 2009, 106: 14478–83. 10.1073/pnas.0900198106View ArticlePubMed CentralPubMed
- Dafou D, Grun B, Sinclair J, Lawrenson K, Benjamin EC, Hogdall E, Kruger-Kjaer S, Christensen L, Sowter HM, Al-Attar A, Edmondson R, Darby S, Berchuck A, Laird PW, Pearce CL, Ramus SJ, Jacobs IJ, Gayther SA: Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers. Neoplasia 2010, 12: 579–89.View ArticlePubMed CentralPubMed
- Notaridou M, Quaye L, Dafou D, Jones C, Song H, Høgdall E, Kjaer SK, Christensen L, Høgdall C, Blaakaer J, McGuire V, Wu AH, Van Den Berg DJ, Pike MC, Gentry-Maharaj A, Wozniak E, Sher T, Jacobs IJ, Tyrer J, Schildkraut JM, Moorman PG, Iversen ES, Jakubowska A, Mędrek K, Lubiński J, Ness RB, Moysich KB, Lurie G, Wilkens LR, Carney ME, et al.: Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. Int J Cancer 2011, 128: 2063–74. 10.1002/ijc.25554View ArticlePubMed CentralPubMed
- Nakabayashi K, Ogino H, Michishita E, Satoh N, Ayusawa D: Introduction of chromosome 7 suppresses telomerase with shortening of telomeres in a human mesothelial cell line. Exp Cell Res 1999, 252: 376–82. 10.1006/excr.1999.4619View ArticlePubMed
- Backsch C, Wagenbach N, Nonn M, Leistritz S, Stanbridge E, Schneider A, Dürst M: Microcell-mediated transfer of chromosome 4 into HeLa cells suppresses telomerase activity. Genes Chromosomes Cancer 2001, 31: 196–8. 10.1002/gcc.1134View ArticlePubMed
- Abe S, Tanaka H, Notsu T, Horike S, Fujisaki C, Qi DL, Ohhira T, Gilley D, Oshimura M, Kugoh H: Localization of an hTERT repressor region on human chromosome 3p21.3 using chromosome engineering. Genome Integr 2010, 26: 6.View Article
- Qi DL, Ohhira T, Fujisaki C, Inoue T, Ohta T, Osaki M, Ohshiro E, Seko T, Aoki S, Oshimura M, Kugoh H: Identification of PITX1 as a TERT suppressor gene located on human chromosome 5. Mol Cell Biol 2011, 31: 1624–36. 10.1128/MCB.00470-10View ArticlePubMed CentralPubMed
- Klein CB, Conway K, Wang XW, Bhamra RK, Lin XH, Cohen MD, Annab L, Barrett JC, Costa M: Senescence of nickel-transformed cells by an X chromosome: possible epigenetic control. Science 1991, 251: 796–9. 10.1126/science.1990442View ArticlePubMed
- Kugoh H, Fujiwara M, Kihara K, Fukui I, Horikawa I, Schulz TC, Oshimura M: Cellular senescence of a human bladder carcinoma cell line (JTC-32) induced by a normal chromosome 11. Cancer Genet Cytogenet 2000, 116: 158–63. 10.1016/S0165-4608(99)00138-7View ArticlePubMed
- Poignée M, Backsch C, Beer K, Jansen L, Wagenbach N, Stanbridge EJ, Kirchmayr R, Schneider A, Dürst M: Evidence for a putative senescence gene locus within the chromosomal region 10p14-p15. Cancer Res 2001, 61: 7118–21.PubMed
- Jeggo PA, Hafezparast M, Thompson AF, Broughton BC, Kaur GP, Zdzienicka MZ, Athwal RS: Localization of a DNA repair gene (XRCC5) involved in double-strand-break rejoining to human chromosome 2. Proc Natl Acad Sci USA 1992, 89: 6423–7. 10.1073/pnas.89.14.6423View ArticlePubMed CentralPubMed
- Chen DJ, Marrone BL, Nguyen T, Stackhouse M, Zhao Y, Siciliano MJ: Regional assignment of a human DNA repair gene (XRCC5) to 2q35 by X-ray hybrid mapping. Genomics 1994, 21: 423–7. 10.1006/geno.1994.1287View ArticlePubMed
- Whitney M, Thayer M, Reifsteck C, Olson S, Smith L, Jakobs PM, Leach R, Naylor S, Joenje H, Grompe M: Microcell mediated chromosome transfer maps the Fanconi anaemia group D gene to chromosome 3p. Nat Genet 1995, 11: 341–3. 10.1038/ng1195-341View ArticlePubMed
- Upender MB, Habermann JK, McShane LM, Korn EL, Barrett JC, Difilippantonio MJ, Ried T: Chromosome transfer induced aneuploidy results in complex dysregulation of the cellular transcriptome in immortalized and cancer cells. Cancer Res 2004, 64: 6941–9. 10.1158/0008-5472.CAN-04-0474View ArticlePubMed
- Nawata H, Kashino G, Tano K, Daino K, Shimada Y, Kugoh H, Oshimura M, Watanabe M: Dysregulation of gene expression in the artificial human trisomy cells of chromosome 8 associated with transformed cell phenotypes. PLoS One 2011, 6: e25319. 10.1371/journal.pone.0025319View ArticlePubMed CentralPubMed
- Meguro M, Mitsuya K, Sui H, Shigenami K, Kugoh H, Nakao M, Oshimura M: Evidence for uniparental, paternal expression of the human GABAA receptor subunit genes, using microcell-mediated chromosome transfer. Hum Mol Genet 1997, 6: 2127–33. 10.1093/hmg/6.12.2127View ArticlePubMed
- Kugoh H, Mitsuya K, Meguro M, Shigenami K, Schulz TC, Oshimura M: Mouse A9 cells containing single human chromosomes for analysis of genomic imprinting. DNA Res 1999, 6: 165–72. 10.1093/dnares/6.3.165View ArticlePubMed
- Inoue J, Mitsuya K, Maegawa S, Kugoh H, Kadota M, Okamura D, Shinohara T, Nishihara S, Takehara S, Yamauchi K, Schulz TC, Oshimura M: Construction of 700 human/mouse A9 monochromosomal hybrids and analysis of imprinted genes on human chromosome 6. J Hum Genet 2001, 46: 137–45. 10.1007/s100380170101View ArticlePubMed
- Doherty AM, Fisher EM: Microcell-mediated chromosome transfer (MMCT): small cells with huge potential. Mamm Genome 2003, 14: 583–92. 10.1007/s00335-003-4002-0View ArticlePubMed
- Anderson MJ, Stanbridge EJ: Tumor suppressor genes studied by cell hybridization and chromosome transfer. FASEB J 1993, 7: 826–833.PubMed
- Meaburn KJ, Parris CN, Bridger JM: The manipulation of chromosomes by mankind: the uses of microcell-mediated chromosome transfer. Chromosoma 2005, 114: 263–74. 10.1007/s00412-005-0014-8View ArticlePubMed
- Winger QA, De La Fuente R, King WA, Armstrong DT, Watson AJ: Bovine parthenogenesis is characterized by abnormal chromosomal complements: implications for maternal and paternal co-dependence during early bovine development. Dev Genet 1997, 21: 160–6. 10.1002/(SICI)1520-6408(1997)21:2<160::AID-DVG5>3.0.CO;2-5View ArticlePubMed
- De La Fuente R, King WA: Developmental consequences of karyokinesis without cytokinesis during the first mitotic cell cycle of bovine parthenotes. Biol Reprod 1998, 58: 952–62. 10.1095/biolreprod58.4.952View ArticlePubMed
- Hao YH, Lai LX, Liu ZH, Im GS, Wax D, Samuel M, Murphy CN, Sutovsky P, Prather RS: Developmental competence of porcine parthenogenetic embryos relative to embryonic chromosomal abnormalities. Mol Reprod Dev 2006, 73: 77–82. 10.1002/mrd.20358View ArticlePubMed
- Angell RR, Templeton AA, Aitken RJ: Chromosome studies in human in vitro fertilization. Hum Genet 1986, 72: 333–9. 10.1007/BF00290960View ArticlePubMed
- Munné S, Lee A, Rosenwaks Z, Grifo J, Cohen J: Diagnosis of major chromosome aneuploidies in human preimplantation embryos. Hum Reprod 1993, 8: 2185–91.PubMed
- Pellestor F, Girardet A, Andréo B, Arnal F, Humeau C: Relationship between morphology and chromosomal constitution in human preimplantation embryo. Mol Reprod Dev 1994, 39: 141–6. 10.1002/mrd.1080390204View ArticlePubMed
- Clouston HJ, Herbert M, Fenwick J, Murdoch AP, Wolstenholme J: Cytogenetic analysis of human blastocysts. Prenat Diagn 2002, 22: 1143–52. 10.1002/pd.502View ArticlePubMed
- Shaver EL, Carr DH: Chromosome abnormalities in rabbit blastocysts following delayed fertilization. J Reprod Fertil 1967, 14: 415–20. 10.1530/jrf.0.0140415View ArticlePubMed
- Modlinski JA: Transfer of embryonic nuclei to fertilized mouse eggs and development of tetraploid blastocysts. Nature 1978, 273: 466–7. 10.1038/273466a0View ArticlePubMed
- Vichera G, Olivera R, Sipowicz P, Radrizzani M, Salamone D: Sperm genome cloning used in biparental bovine embryo reconstruction. Reprod Fertil Dev 2011, 23: 769–79.View ArticlePubMed
- Vichera G, Olivera R, Salamone D: Oocyte genome cloning used in biparental bovine embryo reconstruction. Zygote 2012, 5: 1–9.
- McGrath J, Solter D: Nuclear transplantation in mouse embryo by microsurgery and cell fusion. Science 1983, 220: 1300–1302. 10.1126/science.6857250View ArticlePubMed
- Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH: Viable offspring derived from fetal and adult mammalian cells. Nature 1997, 385: 810–813. 10.1038/385810a0View ArticlePubMed
- Dominko T, Mitalipova M, Haley B, Beyhan Z, Memili E, McKusick B, First NL: Bovine oocyte cytoplasm supports development of embryos produced by nuclear transfer of somatic cell nuclei from various mammalian species. Biol Reprod 1999, 60: 1496–1502. 10.1095/biolreprod60.6.1496View ArticlePubMed
- Wakayama T, Yanagimachi R: The first polar body can be used for the production of normal offspring in mice. Biol Reprod 1998, 59: 100–4. 10.1095/biolreprod59.1.100View ArticlePubMed
- Meng Q, Bai C, Liu Y, Wu X, Bunch TD, Li GP: In vitro development and chromosomal configuration of bovine somatic cloned embryos with nonenucleated metaphase II oocytes. Cell Reprogram 2010, 12: 481–90. 10.1089/cell.2009.0114View ArticlePubMed
- Pereyra-Bonnet F, Bevacqua R, La Rosa I, Sipowicz P, Radrizzani M, Fernandez-Martin R, Salamone D: Novel methods to induce exogenous gene expression in SCNT, parthenogenic and IVF preimplantation bovine embryos. Transgenic Res 2011, 20: 1379–88. 10.1007/s11248-011-9503-0View ArticlePubMed
- Katoh M, Kazuki Y, Kazuki K, Kajitani N, Takiguchi M, Nakayama Y, Nakamura T, Oshimura M: Exploitation of the interaction of measles virus fusogenic envelope proteins with the surface receptor CD46 on human cells for microcell-mediated chromosome transfer. BMC Biotechnol 2010, 10: 37. 10.1186/1472-6750-10-37View ArticlePubMed CentralPubMed
- Littlefield JW: The use of drug-resistant markers to study the hybridization of mouse fibroblasts. Exp Cell Res 1966, 41: 190–196. 10.1016/0014-4827(66)90558-1View ArticlePubMed
- Horibata K, Iwamoto Y, Kuraoka I, Jaspers NG, Kurimasa A, Oshimura M, Ichihashi M, Tanaka K: Complete absence of Cockayne syndrome group B gene product gives rise to UV-sensitive syndrome but not Cockayne syndrome. Proc Natl Acad Sci USA 2004, 101: 15410–5. 10.1073/pnas.0404587101View ArticlePubMed CentralPubMed
- De Lonlay P, Mugnier C, Sanlaville D, Chantrel-Groussard K, Bénit P, Lebon S, Chrétien D, Kadhom N, Saker S, Gyapay G, Romana S, Weissenbach J, Munnich A, Rustin P, Rötig A: Cell complementation using Genebridge 4 human: rodent hybrids for physical mapping of novel mitochondrial respiratory chain deficiency genes. Hum Mol Genet 2002, 11: 3273–81. 10.1093/hmg/11.26.3273View ArticlePubMed
- Bevacqua RJ, Pereyra-Bonnet F, Olivera R, Hiriart MI, Sipowicz P, Fernandez-Martín R, Radrizzani M, Salamone DF: Production of IVF transgene-expressing bovine embryos using a novel strategy based on cell cycle inhibitors. Theriogenology 2012, 78: 57–68. 10.1016/j.theriogenology.2012.01.020View ArticlePubMed
- Boyle S, Gilchrist S, Bridger J, Mahy N, Ellis J, Bickmore W: The spatial organization of human chromosomes within the nuclei of normal and emerin-mutant cells. Hum Mol Genet 2001, 10: 211–219. 10.1093/hmg/10.3.211View ArticlePubMed
- Spann TP, Goldman AE, Wang C, Huang S, Goldman RD: Alteration of nuclear lamin organization inhibits RNA polymerase II-dependent transcription. J Cell Biol 2002, 156: 603–8. 10.1083/jcb.200112047View ArticlePubMed CentralPubMed
- Hyttel P, Viuff D, Avery B, Laurincik J, Greve T: Transcription and cell cycle-dependent development of intranuclear bodies and granules in two-cell bovine embryos. J Reprod Fertil 1996, 108: 263–270. 10.1530/jrf.0.1080263View ArticlePubMed
- Viuff D, Hyttel P, Avery B, Vajta G, Greve T, Callesen H, Thomsen PD: Ribosomal ribonucleic acid is transcribed at the 4-cell stage in in vitro-produced bovine embryos. Biol Reprod 1998, 59: 626–631. 10.1095/biolreprod59.3.626View ArticlePubMed
- Memili E, First NL: Control of gene expression at the onset of bovine embryonic development. Biol Reprod 1999, 61: 1198–1207. 10.1095/biolreprod61.5.1198View ArticlePubMed
- Frei RE, Schultz GA, Church RB: Qualitative and quantitative changes in protein synthesis occur at the 8–16-cell stage of embryogenesis in the cow. J Reprod Fertil 1989, 86: 637–641. 10.1530/jrf.0.0860637View ArticlePubMed
- Memili E, Dominko T, First NL: Onset of transcription in bovine oocytes and preimplantation embryos. Mol Reprod Dev 1998, 51: 36–41. 10.1002/(SICI)1098-2795(199809)51:1<36::AID-MRD4>3.0.CO;2-XView ArticlePubMed
- Canel N, Bevacqua R, Fernández-Martín R, Salamone DF: Activation with ionomycin followed by dehydroleucodine and cytochalasin B for the production of parthenogenetic and cloned bovine embryos. Cell Reprogram 2010, 12: 491–9. 10.1089/cell.2009.0109View ArticlePubMed
- Bhak JS, Lee SL, Ock SA, Mohana Kumar B, Choe SY, Rho GJ: Developmental rate and ploidy of embryos produced by nuclear transfer with different activation treatments in cattle. Anim Reprod Sci 2006, 92: 37–49. 10.1016/j.anireprosci.2005.04.016View ArticlePubMed
- Yoo JG, Choe SY, Rho GJ: Efficient production of cloned bovine embryos using cdc2 kinase inhibitor. Reprod Domest Anim 2003, 38: 444–450. 10.1046/j.0936-6768.2003.00461.xView ArticlePubMed
- Ikawa M, Kominami K, Yoshimura Y, Tanaka K, Nishimune Y, Okabe M: A rapid and non-invasive selection of transgenic embryos before implantation using green fluorescent protein (GFP). FEBS Lett 2005, 375: 125–128.View Article
- Brackett B, Oliphant G: Capacitation of rabbit spermatozoa in vitro. Biol Reprod 1975, 12: 260–274. 10.1095/biolreprod12.2.260View ArticlePubMed
- Tervit H, Whittingham D, Rowson L: Successful culture in vitro of sheep and cattle ova. J Reprod Fertil 1972, 30: 493–497. 10.1530/jrf.0.0300493View ArticlePubMed
- Holm P, Booth PJ, Schmidt MH, Greve T, Callesen H: High bovine blastocyst development in a static in vitro production system using SOFaa medium supplemented with sodium citrate and myo-inositol with or without serum-proteins. Theriogenology 1999, 52: 683–700. 10.1016/S0093-691X(99)00162-4View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.